Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience
about
Acute Myeloid Leukemia: A Concise ReviewAcute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.Access of primary and secondary literature by health personnel in an academic health center: implications for open access.Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase.Age-specific distributions of cytogenetic subgroups of acute myeloid leukemia: data analysis in a Chinese population.Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal KaryotypesUnsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia.Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogeneticsAcute myeloid leukemia: 2014 update on risk-stratification and management.Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation.Similarities and differences between therapy-related and elderly acute myeloid leukemia.Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemiaA multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyPrognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.Impact of body-mass index on the outcome of adult patients with acute myeloid leukemiaSingle monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotypeImpact of residual normal metaphases in core binding factor acute myeloid leukemiaClinical experience using vitamin d and analogs in the treatment of myelodysplasia and acute myeloid leukemia: a review of the literature.Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid MalignanciesKaryotype complexity and prognosis in acute myeloid leukemia.Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AMLSequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia.Decitabine in the treatment of acute myeloid leukemia in elderly patients.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Older patients with acute myeloid leukemia.Acute myeloid leukaemia in the elderly: a review.Unfavorable-risk cytogenetics in acute myeloid leukemia.How to manage high-risk acute myeloid leukemia.Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia.Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensusAllogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
P2860
Q26766719-0BE1073C-8D5F-4C46-943C-B3D40D199AFDQ27851694-EEFE220D-78B8-4C44-A112-150C20EFF697Q30486319-EE51DCA9-FFA5-4354-9F3F-5AADC66E24E9Q30525568-ED9E3BD6-EE67-4569-BC8E-52FFB0DA8CEBQ30582619-C0FAA6BE-D3B0-4237-AC9A-9312E454D629Q33574178-A5814FC9-3699-4F73-BC1F-15284035B2C7Q33716486-160BD0B3-5005-48A5-A3B7-5B085819346BQ33981864-CCC5A20C-9E78-46F9-B575-73EBD17B47B0Q34205736-8F22008F-2A39-44E2-A090-4E9930EB1DF9Q34665691-8E66ACD1-18A2-47B4-B4F9-B9F8569A747CQ35082499-20847313-8D94-4C78-AD38-2275A371C2DAQ35146284-A4F9DF92-4EEC-4F92-B381-FB195555E3B5Q35164246-0E5AB2AE-39C4-40A2-A056-7DCE8EE82481Q35640731-0B9ABDB0-7798-4D6B-B097-B31569E97625Q35641272-20C08A6C-E24A-441E-8B51-C1E65700F5A6Q35671452-3DA9614B-95BA-4E5F-90EE-BD266025641CQ35794439-A63C40DE-1A04-4AAF-B53F-8374DCD777E0Q36006412-12DB80B4-BD11-48A4-AA0B-DD811A894D32Q36216242-5AC06DFC-D793-40B1-913B-DA70BDB4B491Q36254242-227547A6-90A8-4CB2-A680-F6B62BC8998DQ36375411-615F680A-F941-4061-9B42-07B16801D300Q36417543-A601AED0-61CB-4680-9335-8976F0FCF883Q36474066-301131C3-C2E4-4A3A-9848-01C46D026DA5Q36548075-DBEA38AB-96D7-4431-9125-78FC5C064BC4Q36797201-ABB30321-3790-4896-BB46-C134051281EDQ36862505-2CC8748B-55FC-4658-A94A-CE7A668EA605Q37568244-88882E32-0BCE-4329-BE2E-320DE01DBBCDQ37624593-5DF4CB97-C514-46A0-A228-88618CB1F77FQ37810969-71B6770F-03D9-435B-AD05-9230D2179868Q37840260-72420D9D-7518-42BE-B390-48A8D25B8973Q37865545-649D7B90-4F92-4F65-BA8B-4D4B47202AC8Q37960820-1012D16B-4C5F-4C8B-A083-A19D5D211E1FQ38015268-19ECD574-A798-4560-AA50-832DEAE93C41Q38062865-674316E7-2413-4295-8704-A355DEC9D559Q38106983-309F7ECC-AA91-4821-B427-FB8B1868E099Q38207595-4563236F-7D53-46DF-AF8D-58D292C89620Q38213704-436BA66D-1084-44BB-A398-557A684BDC0AQ38248427-CFDFBEBE-41F7-400B-ACEC-5F070246D68EQ38657161-3A152BB1-A412-4642-B4B5-9C9973E1CF8EQ38760193-84E73012-A74F-4ACE-8EC3-A54C0BB7B343
P2860
Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic impact of monosomal ...... cology Group (SWOG) experience
@en
Prognostic impact of monosomal ...... : the Southwest Oncology Group
@nl
type
label
Prognostic impact of monosomal ...... cology Group (SWOG) experience
@en
Prognostic impact of monosomal ...... : the Southwest Oncology Group
@nl
prefLabel
Prognostic impact of monosomal ...... cology Group (SWOG) experience
@en
Prognostic impact of monosomal ...... : the Southwest Oncology Group
@nl
P2093
P2860
P1433
P1476
Prognostic impact of monosomal ...... cology Group (SWOG) experience
@en
P2093
Bruno C Medeiros
Diane Roulston
P2860
P304
P356
10.1182/BLOOD-2010-02-270330
P407
P577
2010-06-18T00:00:00Z